New single cell and spatial innovations extend 10x Genomics' technology and performanceleadership across all three platforms PLEASANT ...

Highlights of 10x's forthcoming innovations in single ... sample- and species- agnostic multiplexing approach for single-cell RNA sequencing Poster 439: In Situ detection of HPV expression in ...

Highlights of 10x's forthcoming innovations in single cell analysis ... sample- and species- agnostic multiplexing approach for single-cell RNA sequencing Poster 439: In Situ detection of HPV ...

Feb. 23, 2025 /PRNewswire/ -- At the Advances in Genome Biology and Technology (AGBT) General Meeting, 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced a ...

Genomics announced that its ATAC-Seq patents were found valid and infringed in its patent litigation with Parse Biosciences.

Feb. 23, 2025 /PRNewswire/ -- At the Advances in Genome Biology and Technology (AGBT) General Meeting, 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology ... high quality ...

Genomics (TXG) provided an update on its patent litigation with Parse Biosciences. Through a consent agreement entered on February 25, in ...

or offering for sale its planned ATAC and ATAC-Multiome Single Cell products. As part of the agreement, Parse admitted that 10x Genomics' ATAC-seq patents are valid, enforceable, and had been ...

At the Advances in Genome Biology and Technology, AGBT, General Meeting, 10x Genomics (TXG) announced a series of new product innovations to ...